This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tai, C.-T. Articles by Chang, M.-S. Search for Related Content PubMed PubMed Citation Articles by Tai, C.-T. Articles by Chang, M.-S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMIODARONE HYDROCHLORIDE

(Circulation. 1998;97:1935-1945.)
© 1998 American Heart Association, Inc.

Clinical Investigation and Reports

Electropharmacologic Effects of Class I and Class III Antiarrhythmia Drugs on Typical Atrial Flutter

Insights Into the Mechanism of Termination

Ching -Tai Tai, MD; Shih-Ann Chen, MD; An-Ning Feng, MD; Wen-Chung Yu, MD; Yi-Jen Chen, MD; ; Mau-Song Chang, MD

From the Division of Cardiology, Department of Medicine, National Yang-Ming University, School of Medicine, Veterans General Hospital-Taipei, Taiwan, ROC.

Correspondence to Shih-Ann Chen, MD, Division of Cardiology, Department of Medicine, Veterans General Hospital-Taipei, 201 Sec 2. Shih-Pai Road, Taipei, Taiwan, ROC. E-mail sachen{at}vghtpe.gov.tw

Background—Acute effects of class I and class III antiarrhythmia drugs on the reentrant circuit of typical atrial flutter are not fully studied. Furthermore, the critical electrophysiologic determinants of flutter termination by antiarrhythmia drugs are not clear.

Methods and Results—The study population consisted of 36 patients (mean age, 53±17 years) with clinically documented typical atrial flutter. A 20-pole "halo" catheter was positioned around the tricuspid annulus. Incremental pacing was performed to measure the conduction velocity along the isthmus and lateral wall, and extrastimulation was performed to evaluate atrial refractory period in the baseline state and after intravenous infusion of ibutilide, propafenone, and amiodarone. Efficacy of these drugs in conversion of typical atrial flutter and patterns of termination were also determined. Ibutilide significantly increased the atrial refractory period and decreased conduction velocity in the isthmus at short pacing cycle length. It terminated atrial flutter in 8 (67%) of 12 patients after prolongation of flutter cycle length due to increase (86±19%) of conduction time in the isthmus. Propafenone predominantly decreased conduction velocity with use dependency and significantly increased atrial refractory period, but it only converted atrial flutter in 4 (33%) of 12 patients. Amiodarone had fewer effects on atrial refractory period and conduction velocity than did ibutilide and propafenone, and it terminated atrial flutter in only 4 (33%) of 12 patients. Termination of typical atrial flutter was due to failure of wave front propagation through the isthmus, which occurred with cycle length oscillation, abruptly without variability of cycle length, or after premature activation of the reentrant circuit.

Conclusions—Ibutilide, with a unique increase in atrial refractoriness, was more effective in conversion of atrial flutter than were propafenone and amiodarone.

Key Words: atrial flutter • antiarrhythmia agents • drugs

This article has been cited by other articles:

				M. Gulizia, S. Mangiameli, S. Orazi, G. Chiaranda, G. Boriani, G. Piccione, N. DiGiovanni, A. Colletti, C. Puntrello, G. Butera, et al. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device Europace, July 1, 2006; 8(7): 465 - 473. [Abstract] [Full Text] [PDF]

				S. Yamada, K. Tsukada, T. Miyashita, K. Kuga, and I. Yamaguchi Noninvasive, direct visualization of macro-reentrant circuits by using magnetocardiograms: initiation and persistence of atrial flutter Europace, January 1, 2003; 5(4): 343 - 350. [Abstract] [Full Text] [PDF]

				J. Cheng, K. Glatter, Y. Yang, S. Zhang, R. Lee, and M. M. Scheinman Electrophysiological Response of the Right Atrium to Ibutilide During Typical Atrial Flutter Circulation, August 13, 2002; 106(7): 814 - 819. [Abstract] [Full Text] [PDF]

				M. Disertori, L. Padeletti, M. Santini, P. Dini, M. Gasparini, G. Inama, M. Botto, G. Boriani, A. Capucci, R. Ricci, et al. Antitachycardia pacing therapies to terminate atrial tachyarrhythmias: the AT500 Italian Registry Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P16 - P24. [Abstract] [PDF]

				K. A. Glatter, P. C. Dorostkar, Y. Yang, R. J. Lee, G. F. Van Hare, E. Keung, G. Modin, and M. M. Scheinman Electrophysiological Effects of Ibutilide in Patients With Accessory Pathways Circulation, October 16, 2001; 104(16): 1933 - 1939. [Abstract] [Full Text] [PDF]

				K. Glatter, Y. Yang, K. Chatterjee, G. Modin, J. Cheng, S. Kayser, and M. M. Scheinman Chemical Cardioversion of Atrial Fibrillation or Flutter With Ibutilide in Patients Receiving Amiodarone Therapy Circulation, January 16, 2001; 103(2): 253 - 257. [Abstract] [Full Text] [PDF]

				D. Li, A. Benardeau, and S. Nattel Contrasting Efficacy of Dofetilide in Differing Experimental Models of Atrial Fibrillation Circulation, July 4, 2000; 102(1): 104 - 112. [Abstract] [Full Text] [PDF]

				J. Cheng, W. R. Cabeen Jr, and M. M. Scheinman Right Atrial Flutter Due to Lower Loop Reentry : Mechanism and Anatomic Substrates Circulation, April 6, 1999; 99(13): 1700 - 1705. [Abstract] [Full Text] [PDF]